School of Molecular Sciences

Industry and community partnerships

• iCeutica
  Visit the iCeutica website
• Medela

  Medela is a global leader in the development and production of breast milk feeding products and solutions.

  Founded in 1961 by Olle Larsson and headquartered in Switzerland, Medela is today led by his son Michael Larsson and consists of 18 subsidiaries located throughout Europe, North America and Asia.

  As a research-based company Medela invests in basic and exploratory research in partnership with leading scientists, medical professionals and universities around the world, and uses these research results in the development of its breastfeeding products and solutions.

  Since 1996 Medela has fostered a rewarding research partnership with Emeritus Professor Peter Hartmann and Associate Professor Donna Geddes from our School.

  This collaboration has provided for: 16 full or partial PhD scholarships; 84 peer reviewed journal articles; 21 book chapters; 195 conference abstracts, and has made a significant impact on our understanding of mammary gland function and human lactation.

  Visit the Medela website

• Proteomics International

  Proteomics International is a medical technology company focused on proteomics – the industrial scale study of the structure and function of proteins. Established in 2001, the company received the world’s first ISO 17025 laboratory accreditation for proteomics services, and operates from state-of-the art facilities at the Harry Perkins Institute of Medical Research in Perth. Proteomics International operates in three integrated areas unified by its proprietary proteomics-based technology platform: Diagnostics, Peptide drug discovery and Analytical services (specialising in biosimilars and biologics). Strategic collaborations are also in place between the company and UWA to encourage the translation of scientific research into industry, and maximise the capacity of technology and facilities.

  Visit the Proteomics International website

• Australian Vanadium Ltd

  Australian Vanadium Ltd (ASX:AVL) is a vertically-integrated battery metals company focussing on energy storage. AVL is progressing the greenfield 'Gabanintha' vanadium deposit, south of Meekatharra in Western Australia. It is also exploring a lithium deposit in South Africa.

  Vanadium is traditionally used to strengthen steel, but emerging demand is coming from the energy storage market.

  Vanadium in electrolyte solution is used in vanadium redox flow batteries (VRB) to store energy. AVL is utilising laboratory space at UWA to electrochemically produce and analytically test vanadium electrolyte with staff and students. In collaboration with the University the company aims to research commercial advancements in vanadium storage. AVL’s subsidiary, VSUN Energy, sold and commissioned WA’s first VRB.

  Visit the Australian Vanadium Ltd website

• Pharmaxis

  Pharmaxis is a publicly listed Australian pharmaceutical research company with a portfolio including two respiratory products approved in various world markets and an established research pipeline focused on areas of high unmet clinical need in inflammatory and fibrotic diseases.

  Pharmaxis collaborates with UWA’s School of Molecular Sciences and School of Biological Sciences on neuroinflammation.

  This project is combining Pharmaxis' knowledge in developing anti-inflammatory drugs with UWA experience in in vitro and in vivo models of neuroinflammation.

  Pharmaxis research laboratories and purpose-built manufacturing facilities are located at the company's headquarters in Sydney.

  Visit the Pharmaxis website

• Perth Mint
  Visit the Perth Mint website